957POverall and progression-free survival according to...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

957POverall and progression-free survival according to MSKCC scores in 1st line sunitinib treatment of metastatic renal cell carcinoma (mRCC)

Finek, J, Poprach, A, Melichar, B, Kopecky, J, Zemanova, M, Buchler, T, Kopeckova, K, Mlcoch, T, Dolezal, T, Fiala, O
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz249.053
Date:
October, 2019
File:
PDF, 75 KB
2019
Conversion to is in progress
Conversion to is failed